Venneos GmbH, a Stuttgart, Germany-based developer of a novel imaging system for the analysis of biological cells, raised €1m in seed funding.
Backers included a consortium of business angels and family offices, along with the High-Tech Gründerfonds and Max Planck Society.
The company intends to use the funds to develop a market-ready product and prepare the market entry of the first product generation.
Founded by Jonas Lehmann as a spin-off from the Max Planck Society, Venneos is developing a silicon-chip-based imaging system for the analysis of biological cells. The system builds upon an innovative measurement approach that allows customers to detect cellular changes which remain invisible with other technologies.
At the moment, the company is cooperating with pilot customers to develop the prototype further. For further development, Venneos is currently looking for employees at the intersection of physics, electrical engineering, computer science and biology.